4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-25-000002
Chief Financial Officer sold 3,594 shares at $15.00 ($53,910)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goeltz II Robert C. Chief Financial Officer | 2024-12-31 | Sale 10b5-1 | −3,594 | $15.00 | $53,910 | 60,138 | D |
| Open-market sales · 3,594 sh · avg $15.00 · $53,910 | |||||||
Loading xslF345X05/wk-form4_1735938476.xml…